Your browser doesn't support javascript.
loading
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Duployez, Nicolas; Largeaud, Laëtitia; Duchmann, Matthieu; Kim, Rathana; Rieunier, Julie; Lambert, Juliette; Bidet, Audrey; Larcher, Lise; Lemoine, Jean; Delhommeau, François; Hirsch, Pierre; Fenwarth, Laurène; Kosmider, Olivier; Decroocq, Justine; Bouvier, Anne; Le Bris, Yannick; Ochmann, Marlène; Santagostino, Alberto; Adès, Lionel; Fenaux, Pierre; Thomas, Xavier; Micol, Jean-Baptiste; Gardin, Claude; Itzykson, Raphael; Soulier, Jean; Clappier, Emmanuelle; Recher, Christian; Preudhomme, Claude; Pigneux, Arnaud; Dombret, Hervé; Delabesse, Eric; Sébert, Marie.
Affiliation
  • Duployez N; Hematology Laboratory, Unité 1277-Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, INSERM, Lille, France.
  • Largeaud L; Hematology Laboratory, CHU de Toulouse-Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Duchmann M; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Kim R; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Rieunier J; Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Lambert J; Hematology Laboratory, CHU de Toulouse-Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Bidet A; Hematology Department, Versailles Hospital, Le Chesnay, France.
  • Larcher L; Hematology Laboratory, CHU de Bordeaux, Bordeaux, France.
  • Lemoine J; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Delhommeau F; Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Hirsch P; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France.
  • Fenwarth L; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Laboratoire d'hématologie biologique, Hôpital Saint-Antoine, Paris, France.
  • Kosmider O; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Laboratoire d'hématologie biologique, Hôpital Saint-Antoine, Paris, France.
  • Decroocq J; Hematology Laboratory, Unité 1277-Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, INSERM, Lille, France.
  • Bouvier A; Hematology Laboratory, Cochin Hospital, AP-HP, Paris, France.
  • Le Bris Y; Hematology Department, Cochin Hospital, AP-HP, Paris, France.
  • Ochmann M; Hematology Laboratory, CHU Angers, Angers, France.
  • Santagostino A; Hematology Biology, Nantes University Hospital, Nantes, France.
  • Adès L; CRCINA, INSERM, CNRS, Université de Nantes, Université d'Angers, Nantes, France.
  • Fenaux P; Hematology Department, CHU Orléans, Orléans, France.
  • Thomas X; Hematology Department, CHU Troyes, Troyes, France.
  • Micol JB; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Gardin C; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France.
  • Itzykson R; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Soulier J; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France.
  • Clappier E; Hematology Department, Hospices Civils de Lyon, Lyon-Sud Hospital, Lyon, France.
  • Recher C; Hematology Department, Gustave Roussy Institute, University of Paris-Saclay, Villejuif, France.
  • Preudhomme C; Hematology Department, Avicenne Hospital, AP-HP, Bobigny, France.
  • Pigneux A; Unité 3518, Saint-Louis Institute for Research, Université de Paris, Paris, France.
  • Dombret H; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Delabesse E; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France.
  • Sébert M; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.
Blood ; 140(7): 756-768, 2022 08 18.
Article in En | MEDLINE | ID: mdl-35443031
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2022 Document type: Article